Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting

Table 1

Demographic and clinical characteristics by presence of POAF.

Characteristics	POAF group	No POAF group	value
Sex (male/female)	80/28	300/100	0.844
Age (years)
BMI (kg/m^2)			0.206
Smoking (%)	78 (72.2)	247 (61.8)
Heart rate (beats/min)			0.150
NYHA III-IV (%)	20 (18.5)	68 (17.0)	0.711
Hypertension (%)	76 (70.4)	252 (63.0)	0.155
DM (%)	48 (44.4)	172 (43.0)	0.788
Myocardial infarction (%)	62 (57.4)	203 (50.8)	0.161
Blood glucose (mmol/L)			0.758
Cholesterol (mmol/L)			0.514
Triglyceride (mmol/L)			0.982
LDL (mmol/L)			0.053
HDL (mmol/L)			0.144
Creatinine (umol/L)			0.724
CKMB (U/L)			0.592
cTNT (ng/mL)			0.101
EF			0.064
LAD (mm)
PASP (mmHg)			0.152
LVEDV (mL)
Beta-blockers (%)	97 (89.8)	368 (92.0)	0.469
ACEI (%)	44 (40.7)	184 (46.0)	0.330
CCB (%)	60 (55.6)	204 (51.0)	0.400
Statins (%)	60 (55.6)	284 (71.0)

Notes. Data presented as mean ± standard deviation or as a ratio. value < 0.05; the difference was statistically significant. POAF, postoperative atrial fibrillation; BMI, body mass index; NYHA, New York Heart Association; DM, diabetes mellitus; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CKMB, creatine kinase MB; EF, ejection fraction; LAD, left atrial diameter; PASP, pulmonary arterial systolic pressure; LVEDV, left ventricle end-diastolic volume; ACEI, angiotensin converting enzyme inhibitor; CCB, calcium channel blocker.